Sign In
Buy SAVA
$1.96
+0 (+0%)
At Close: Jun 03, 2026
Cassava Sciences Announces Expansion of Open-Label Extension Trials
08:15am, Tuesday, 30'th Jul 2024
AUSTIN, Texas, July 30, 2024 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (Nasdaq: SAVA) today announced that the Company will extend by up to an additional 36 months each of the open-label extension tr
Get Your Money Out of These 3 Biotech Stocks Before the End of July
09:00am, Sunday, 28'th Jul 2024
Biotech stocks are known for their high volatility and potential for massive gains. The success in the sector often hinges on progressive and often groundbreaking medical advancements.
SAVA Stock Alert: Cassava Sciences Pops on Late-Stage Trial Update
12:08pm, Monday, 22'nd Jul 2024
Cassava Sciences (NASDAQ: SAVA ) stock is up on Monday after the company provided investors with an update for its Phase 3 trial for its Alzheimer's disease treatment. According to a news release from
Why Cassava Sciences Stock Is Skyrocketing Today
11:27am, Monday, 22'nd Jul 2024
New Cassava executive chairman Rick Barry wrote an open letter to stakeholders. Barry acknowledged skepticism but stressed the potential for its Alzheimer's disease candidate simufilam.
SAVA Stock Plunges as Cassava Sciences CEO Steps Down. What to Know.
12:11pm, Wednesday, 17'th Jul 2024
A bad month just got much worse for Cassava Sciences (NASDAQ: SAVA ). SAVA stock is plunging today on news that President and CEO Remi Barbier is stepping down, effective immediately.
Cassava Sciences Announces Changes in Executive Leadership, Enhanced Corporate Governance and Other Initiatives
08:00am, Wednesday, 17'th Jul 2024
AUSTIN, Texas, July 17, 2024 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (Nasdaq: SAVA) today announced that the Board of Directors has appointed Richard (Rick) Barry as Executive Chairman of the Board
3 Healthcare Stocks to Sell in July Before They Crash & Burn
04:45pm, Monday, 08'th Jul 2024
The outlook of many healthcare stocks is quite positive at this point. That's partly because many large investors have shunned the sector, since they believe that it is destined to produce horrible re
Top 5 Health Care Stocks That May Explode In July
08:40am, Monday, 08'th Jul 2024
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.
3 Biotech Stocks to Sell in July Before They Crash & Burn
07:30am, Friday, 05'th Jul 2024
The biotech segment is a relatively new sector that combines the fields of biology and technology. It integrates natural sciences from biology and engineering aspects from technology to develop produc
Why Cassava Sciences Stock Is Sinking Today
12:19pm, Monday, 01'st Jul 2024
A former consultant to Cassava was indicted for alleged fraud related to NIH grants. Cassava received some federal funding related to these grants.
Cassava Sciences Cooperates With DOJ, SEC On Controversial Alzheimer's Drug Investigation
11:19am, Monday, 01'st Jul 2024
Cassava Sciences SAVA has engaged the U.S. Department of Justice (DOJ) and the U.S. Securities and Exchange Commission (SEC) amid ongoing investigations into the company and two senior employees.
SAVA Stock Alert: Former Cassava Science Advisor Charged With Fraud
10:40am, Monday, 01'st Jul 2024
Shares of Cassava Sciences (NASDAQ: SAVA ), which has an Alzheimer's drug candidate called simufilam, fell 35% on June 28 and another 13% over the weekend. This move in SAVA stock comes after a key sc
Cassava Sciences shares fall after onetime advisor indicted on fraud charges
08:41pm, Friday, 28'th Jun 2024
Shares of biotech company Cassava Sciences Inc. plummeted on Friday after a federal grand jury indicted a onetime science advisor to Cassava and charged him with falsifying data to obtain millions of
Cassava Sciences Shares Plunge on Indictment Against Former Advisor
06:33pm, Friday, 28'th Jun 2024
A federal indictment accuses a Cassava Sciences advisor of faking data to secure NIH grants. The company also faces shareholder suits.
Cassava Sciences Issues Statement on Former Science Advisor
03:58pm, Friday, 28'th Jun 2024
AUSTIN, Texas, June 28, 2024 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (Nasdaq: SAVA), reported it has learned today that a federal grand jury returned an indictment charging Hoau-Yan Wang for alleg
